4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-26-308061
Director sold 10,000 shares at an average $88.30 ($882,986)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
WILSON JAMES N · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-15 | Sale : show line 1 in the form 10b5-1 | −1,079 | $86.78 | $93,633 | 1,093,464 | I |
| 2026-07-15 | Sale : show line 2 in the form 10b5-1 | −3,969 | $87.74 | $348,223 | 1,089,495 | I |
| 2026-07-15 | Sale : show line 3 in the form 10b5-1 | −2,974 | $88.81 | $264,122 | 1,086,521 | I |
| 2026-07-15 | Sale : show line 4 in the form 10b5-1 | −1,978 | $89.49 | $177,007 | 1,084,543 | I |
| Open-market sales · 10,000 sh · avg $88.30 · $882,986 | ||||||
Loading xslF345X06/ownership.xml…